Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    February 2019
  1. VAZQUEZ-DOMINGUEZ I, Gonzalez-Sanchez L, Lopez-Nieva P, Fernandez-Navarro P, et al
    Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0746.
    PubMed     Text format     Abstract available


    October 2018
  2. GUO H, Zeng D, Zhang H, Bell T, et al
    Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma.
    Oncogene. 2018 Oct 25. pii: 10.1038/s41388-018-0550.
    PubMed     Text format     Abstract available


    July 2018
  3. ALQARNI S, Al-Sheikh Y, Campbell D, Drotar M, et al
    Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.
    Oncogene. 2018;37:3998-4012.
    PubMed     Text format     Abstract available


    April 2018
  4. HU T, Chong Y, Qin H, Kitamura E, et al
    The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
    Oncogene. 2018;37:1926-1938.
    PubMed     Text format     Abstract available


    March 2018
  5. DING L, Zhang Y, Han L, Fu L, et al
    Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.
    Oncogene. 2018;37:1293-1307.
    PubMed     Text format     Abstract available


    February 2018
  6. DEBERNARDI J, Hollville E, Lipinski M, Wiels J, et al
    Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.
    Oncogene. 2018 Feb 14. pii: 10.1038/s41388-018-0123.
    PubMed     Text format     Abstract available


    January 2018
  7. ESTEVE-ARENYS A, Valero JG, Chamorro-Jorganes A, Gonzalez D, et al
    The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0111.
    PubMed     Text format     Abstract available


    August 2017
  8. MOYO TK, Wilson CS, Moore DJ, Eischen CM, et al
    Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.
    Oncogene. 2017;36:4653-4661.
    PubMed     Text format     Abstract available


    July 2017
  9. GUO X, Koff JL, Moffitt AB, Cinar M, et al
    Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
    Oncogene. 2017;36:4224-4232.
    PubMed     Text format     Abstract available


  10. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    May 2017
  11. TONELLI C, Morelli MJ, Sabo A, Verrecchia A, et al
    Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas.
    Oncogene. 2017;36:2921-2929.
    PubMed     Text format     Abstract available


  12. GOTO H, Kariya R, Kudo E, Okuno Y, et al
    Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  13. PUCCETTI MV, Fischer MA, Arrate MP, Boyd KL, et al
    Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution.
    Oncogene. 2017;36:2553-2564.
    PubMed     Text format     Abstract available


  14. DAI L, Lin Z, Qiao J, Chen Y, et al
    Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    April 2017
  15. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Text format     Abstract available


    February 2017
  16. SAUER M, Schuldner M, Hoffmann N, Cetintas A, et al
    CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells.
    Oncogene. 2017;36:933-941.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: